Hepatitis C: A new direction, but an old story?

The Lancet

Volumn 383, Issue 9935, 2014, Pages 2122-2123

  Gluud, Christian ^a   Koretz, Ronald ^b   Gurusamy, Kurinchi ^c  

^a Mental Health Services CPH   (Denmark)

^b Cochrane Hepato Biliary Group ^*  (United States)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; PROTEINASE INHIBITOR; RIBAVIRIN; INTERFERON;

COST EFFECTIVENESS ANALYSIS; END STAGE LIVER DISEASE; HEALTH CARE PERSONNEL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; VIRAL CLEARANCE; WORLD HEALTH ORGANIZATION; NONHUMAN; RETREATMENT; SYSTEMATIC REVIEW (TOPIC);

ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH;

EID: 84902674968     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)61025-4     Document Type: Letter

References (7)

1. WHO. Guidelines for the screening, care and treatment of persons with hepatitis C infection. 2014. http://www.who.int/hiv/pub/hepatitis/hepatitis-c- guidelines/en/ (accessed June 2, 2014).
2. The Lancet. A new direction for hepatitis C. Lancet 2014; 383: 1270.
3. Gluud C, Brok J, Gong Y, Koretz RL. Hepatology may have problems with putative surrogate outcome measures. J Hepatol 2007; 46: 734-42.
4. Brok J, Gluud LL, Gluud C. Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database Syst Rev 2010; 1: CD005445.
5. Hauser G, Awad T, Brok J, et al. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C. Cochrane Database Syst Rev 2014; 2: CD005441.
6. Koretz RL, Pleguezuelo M, Arvaniti V, et al. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. Cochrane Database Syst Rev 2013; 1: CD003617.
7. Gurusamy KS, Wilson E, Koretz RL, et al. Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention? PLoS One 2013; 8: e83313.